Filter
1291
Text search:
drug
regulation
Featured
89
359
Language
Document type
712
249
163
67
64
11
10
9
3
1
1
Countries / Regions
65
53
50
44
37
36
32
30
29
23
22
21
20
20
20
19
18
17
17
17
15
15
14
14
13
12
11
11
11
11
8
8
7
7
6
6
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
563
82
74
36
29
20
10
Toolboxes
153
127
84
71
52
45
33
33
28
22
18
18
13
13
12
11
11
7
6
6
5
3
3
1
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
Cocaine is a highly addictive and dangerous illicit substance that plague millions of Americans each year. Learn here about the dangers, warning signs, and how cocaine addiction can be treated.
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
WHO Technical Report Series, No. 908, 2003, Annex 9. This guide is intended for those involved in the storage, transportation and distribution of pharmaceuticals. It describes the special measures considered appropriate for the storage and transportation of pharmaceuticals.
National Medicines Policy 2015
recommended
Accessed November, 2017
Therapeutics Information and Pharmacovigilance Centre | TIPC
The purpose of these guidelines is to give practical advice to doctors so that all services and models of care used by doctors and health workers are encouraged to consider the use of telemedicine as a part of normal practice. These guidelines will assist the medical practitioner in pursuing a sound
...
A survey of prevention, testing and treatment policies and practices
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
